CervoMed Inc. Stock Split Ratio
CervoMed Inc. (CRVO) reported Stock Split Ratio of 1.00% for the 0-month period ending 2014-03-07, per its 10-Q filed 2014-11-12.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2015-04-03
- 2014-03-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 1.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month as first filed 10000.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month as first filed | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|---|---|
| 2014-03-07 | 1.00% 10-Q · filed 2014-11-12 | 10000.00% 10-Q · filed 2014-08-14 | 1.00% 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |